BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 35662442)

  • 1. 2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease.
    Hoang TD; Stocker DJ; Chou EL; Burch HB
    Endocrinol Metab Clin North Am; 2022 Jun; 51(2):287-304. PubMed ID: 35662442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Graves Thyroidal and Extrathyroidal Disease: An Update.
    Kahaly GJ
    J Clin Endocrinol Metab; 2020 Dec; 105(12):3704-20. PubMed ID: 32929476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of Graves disease.
    Streetman DD; Khanderia U
    Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Graves' hyperthyroidism: present and future.
    Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
    Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts regarding Graves' orbitopathy.
    Bartalena L; Tanda ML
    J Intern Med; 2022 Nov; 292(5):692-716. PubMed ID: 35604323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Graves Disease: A Review.
    Burch HB; Cooper DS
    JAMA; 2015 Dec; 314(23):2544-54. PubMed ID: 26670972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthyroidism. Current treatment guidelines.
    Gittoes NJ; Franklyn JA
    Drugs; 1998 Apr; 55(4):543-53. PubMed ID: 9561343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease.
    Stein JD; Childers D; Gupta S; Talwar N; Nan B; Lee BJ; Smith TJ; Douglas R
    JAMA Ophthalmol; 2015 Mar; 133(3):290-6. PubMed ID: 25502604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graves' Disease.
    Smith TJ; Hegedüs L
    N Engl J Med; 2016 Oct; 375(16):1552-1565. PubMed ID: 27797318
    [No Abstract]   [Full Text] [Related]  

  • 10. Graves' disease in adults Antithyroid drugs, radioactive iodine, or sometimes thyroidectomy.
    Prescrire Int; 2017 Mar; 26(180):72-77. PubMed ID: 30730622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy.
    Bartalena L
    J Clin Endocrinol Metab; 2011 Mar; 96(3):592-9. PubMed ID: 21190983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.
    Träisk F; Tallstedt L; Abraham-Nordling M; Andersson T; Berg G; Calissendorff J; Hallengren B; Hedner P; Lantz M; Nyström E; Ponjavic V; Taube A; Törring O; Wallin G; Asman P; Lundell G;
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3700-7. PubMed ID: 19723755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graves' disease. Manifestations and therapeutic options.
    McFarland KF; Saleeby G
    Postgrad Med; 1988 Mar; 83(4):275-82. PubMed ID: 2451239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
    Brammen L; Riss P; Lukas J; Gessl A; Dunkler D; Li S; Leisser A; Rezar-Dreindl S; Eibenberger K; Selberherr A; Scheuba C; Papp A
    Trials; 2018 Sep; 19(1):495. PubMed ID: 30219088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between management of hyperthyroidism and course of the ophthalmopathy.
    Bartalena L; Tanda ML; Piantanida E; Lai A; Pinchera A
    J Endocrinol Invest; 2004 Mar; 27(3):288-94. PubMed ID: 15165006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
    Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
    Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for hyperthyroidism.
    Wartofsky L
    Hosp Pract (1995); 1996 Sep; 31(9):69-73, 76-8, 81-4. PubMed ID: 8814121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
    Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of adult Graves' disease.
    Corvilain B; Hamy A; Brunaud L; Borson-Chazot F; Orgiazzi J; Bensalem Hachmi L; Semrouni M; Rodien P; Lussey-Lepoutre C
    Ann Endocrinol (Paris); 2018 Dec; 79(6):618-635. PubMed ID: 30193753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.
    Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.